A case of multiple endocrine neoplasm (MEN) type IIa and 2 cases of MEN type IIb are reported. The biological behavior of medullary thyroid carcinoma was more aggressive in the MEN type IIb. C-cell hyperplasia was present in the thyroid gland of the patient with a positive family history.
Get full access to this article
View all access options for this article.
References
1.
CarneyJ.A.: C-cell disease of the thyroid gland in multiple endocrine neoplasia type 2b.Cancer, 44: 2173–2182, 1979.
2.
ChongG.C., BeahrsO.H., SizemoreG.N., WoolnerL.A.: Medullary carcinoma of the thyroid gland.Cancer, 35: 695–703, 1975.
3.
De LellisR.A., NunnemacherG., WolfeH.J.: C-cell hyperplasia: an ultrastructural analysis.Lab. Invest., 36: 237–248, 1977.
4.
GrazeK., TashjianA.J.Jr., WolfeH.J., De LellisR.A., MillerH.H., GagelR.F., FeldmanZ.T., MelvinK.E.W., ReichlinS.: Provocative test of calcitonin secretion in the early diagnosis of medullary carcinoma and C-cell hyperplasia of the thyroid gland.N. Engl. J. Med., 299: 980–985, 1978.
SteinerA.L., GoodmanA.D., PowersS.R.: Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2.Medicine, 47: 371–409, 1968.
7.
SternbergerL.A.: Immunocytochemistry.Ed. 2, John Wiley and Sons, New York, 1979.
8.
WilliamsE.D., BrownC.L., DoniachI.: Pathological and clinical findings in a series of 67 cases of medullary thyroid carcinoma.J. Clin. Pathol., 19: 103–110, 1966.
9.
WolfeH.J., MelvinK.E.W., Cervi-SkinnerS.J., Al SaadiA.A., JuliarJ.F., JacksonC.E., TashjianA.H.Jr.: C-cell hyperplasia preceding medullary thyroid carcinoma.N. Engl. J. Med., 289: 437–441, 1973.
10.
WolfeH.J., De LellisR.A., JacksonC.F., GreenewaldK.A., BlockM.A., TashjianA.H.Jr.: Immunocytochemical distinction of hereditary from sporadic medullary thyroid carcinoma.Lab. Invest., 42: 292–299, 1980.
11.
ZaatariG.S., SaigoP.E., HuvosA.G.: Mucin production in medullary thyroid carcinoma.Arch. Pathol. Lab. Med., 107: 70–74, 1983.
